WallStSmart
AEON

AEON Biopharma, Inc.

NYSE MKT: AEON · HEALTHCARE · BIOTECHNOLOGY

$0.95
-3.02% today

Updated 2026-04-29

Market cap
$24.16M
P/E ratio
P/S ratio
97.16x
EPS (TTM)
$-3.95
Dividend yield
52W range
$0 – $1
Volume
0.1M

WallStSmart proprietary scores

17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.5
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$6.70
+601.79%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.71M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00
Net income$-52.56M$-384.63M$42.01M$-39.22M$-37.14M
EPS$-3.95
Free cash flow$-35.89M$-47.83M$-20.29M$-17.31M$-4.71M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
AEON$24.16M174.33.55.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

AEON Biopharma, Inc. trades at $0.95. Our Smart Value Score of 17/100 indicates the stock is weak.

Frequently asked questions

What is AEON Biopharma, Inc.'s stock price?
AEON Biopharma, Inc. (AEON) trades at $0.95.
Is AEON Biopharma, Inc. overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of AEON Biopharma, Inc. (AEON)?
The analyst target price is $6.70, representing +601.8% upside from the current price of $0.95.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD

Quick metrics

P/S ratio97.16x
ROE
Beta0.74
50D MA$1.05
200D MA$0.95
Shares out0.03B
Float0.01B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years